Outset Medical, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Outset Medical, Inc. (OM) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $15.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-13
- Outset Medical, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $15.30M, a 30.77% decline from fiscal 2024.
- Outset Medical, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $22.10M, a 41.53% decline from fiscal 2023.
- Outset Medical, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $37.80M, a 11.27% decline from fiscal 2022.
- Outset Medical, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $42.60M, a 38.76% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $15.30M 10-K · filed 2026-02-13 | |
| 2024-12-31 | $22.10M 10-K · filed 2026-02-13 | |
| 2023-12-31 | $37.80M 10-K · filed 2026-02-13 | |
| 2022-12-31 | $42.60M 10-K · filed 2025-02-28 | |
| 2021-12-31 | $30.70M 10-K · filed 2024-02-21 | |
| 2020-12-31 | $28.40M 10-K · filed 2023-02-13 | $28.30M 10-K · filed 2021-03-22 |
| 2019-12-31 | $23.70M 10-K · filed 2022-02-23 | $24.00M 10-K · filed 2021-03-22 |
| 2018-12-31 | $13.60M 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |